What is the global market size of Stem Cell Manufacturing Market?

Stem Cell Manufacturing Market size was valued at USD 11.5 Billion in 2021 and is poised to grow from USD 12.58 Billion in 2022 to USD 25.81 Billion by 2030, at a CAGR of 9.4% during the forecast period (2023-2030).

Who are the key vendors in the Global Stem Cell Manufacturing Market?

The global stem cell manufacturing market features a competitive landscape with several players striving to establish their presence and gain a competitive edge. The market is characterised by the presence of multinational pharmaceutical companies, biotechnology firms, and research institutions. These players are engaged in continuous research and development activities to enhance their stem cell manufacturing capabilities and expand their product portfolios. The competitive landscape is influenced by factors such as technological advancements, product innovation, strategic collaborations, and regulatory compliance. Key players in the market focus on developing advanced manufacturing technologies, optimising cell culture techniques, and improving the scalability and reproducibility of stem cell production. These efforts aim to meet the increasing demand for stem cell-based therapies and capitalise on the market's potential. Moreover, strategic collaborations and partnerships play a crucial role in the competitive landscape of the stem cell manufacturing market. Companies form alliances with research institutions, academic centers, and other industry players to leverage their expertise, access to stem cell lines, and advanced technologies. These collaborations help in accelerating the development and commercialization of novel stem cell therapies and expanding market reach. In addition, regulatory compliance is a critical aspect of the competitive landscape. Stem cell manufacturing is subject to strict regulations and guidelines, and companies that demonstrate compliance with these regulations gain a competitive advantage. Adherence to quality control standards, documentation requirements, and ethical considerations is crucial for market players to ensure the safety and efficacy of their stem cell-based products. 'Thermo Fisher Scientific Inc. - US', 'Lonza Group Ltd. - Switzerland', 'Merck KGaA - Germany', 'FUJIFILM Cellular Dynamics Inc. - US', 'STEMCELL Technologies Inc. - Canada', 'Takara Bio Inc. - Japan', 'GE Healthcare - US', 'Miltenyi Biotec GmbH - Germany', 'PromoCell GmbH - Germany', 'CellGenix GmbH - Germany', 'REPROCELL Inc. - Japan', 'Cellular Dynamics International, a Fujifilm Company - US', 'STEMCELL Clinic - Canada', 'Osiris Therapeutics, Inc. - US', 'Pluristem Therapeutics Inc. - Israel', 'TiGenix NV - Belgium', 'Mesoblast Limited - Australia', 'Cellular Biomedicine Group, Inc. - US', 'Gamida Cell Ltd. - Israel', 'Vericel Corporation - US'

What is the key driver of Global Stem Cell Manufacturing Market?

The rising incidence of chronic diseases, such as cardiovascular disorders, neurological conditions, and cancer, is a key driver for the global stem cell manufacturing market. Stem cells offer potential therapeutic solutions and regenerative treatments for these diseases, driving the demand for stem cell manufacturing.

What is the key market trend for Global Stem Cell Manufacturing Market?

Focus on Ethical and Sustainable Sourcing of Stem Cells: There is a growing emphasis on ethical and sustainable sourcing of stem cells. The use of alternative sources, such as induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs), is gaining traction. Companies are investing in research and development to develop efficient and ethical methods for deriving and culturing stem cells, reducing the reliance on controversial sources.

Which region accounted for the largest share in Global Stem Cell Manufacturing Market?

The dominant region in the stem cell manufacturing market is North America. North America holds a significant share of the global market due to its advanced healthcare infrastructure, robust research and development activities, and strong presence of major pharmaceutical and biotechnology companies. The region has a well-established regulatory framework that supports stem cell research and development, making it an attractive market for stem cell manufacturing. Additionally, the presence of renowned research institutions and academic centers further drives the growth of the stem cell manufacturing market in North America.

Stem Cell Manufacturing Market Size, Share, Growth Analysis, By Product(Consumables (Culture Media, Other Consumables), Instruments (Bioreactors & Incubators, Cell Sorters), By Application (Research Applications (Life Science Research, Drug Discovery & Development), Clinical Applications (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy)), By End User(Pharmaceutical & Biotechnology Companies, Academic Institutes, Research Laboratories, and Contract Research Organizations), By Region - Industry Forecast 2025-2032

Report ID: SQMIG35B2172 | Region: Global | Published Date: October, 2024
Pages: 157 | Tables: 61 | Figures: 75

Stem Cell Manufacturing Market Insights

Stem Cell Manufacturing Market size was valued at USD 13.76 Billion in 2023 and is poised to grow from USD 15.05 Billion in 2024 to USD 30.88 Billion by 2032, growing at a CAGR of 9.4% during the forecast period (2025-2032).

The stem cell manufacturing market growth is driven by the technological innovations in the manufacture and storage of stem cells, along with growing public awareness about the medicinal properties of products related to stem cells. According to a paper in PubMed dated September 2022, the treatment of many diseases by stem cells, based on in vitro and in vivo studies, is considered safe and effective. This treatment is believed to be based on human stem cells, such as iPSCs, ASCs, and ESCs, that are supposed to help in repairing or reconstructing damaged organs and congenital deformities. Many more public and private organizations will combine to address common issues connected with the production and processing of stem cell banks, enhancing operation and driving the growth of the market. For instance, in the last quarter of 2021, STEMCELL Technologies launched human pluripotent stem cell characterization and banking services in collaboration with WiCell. The services, provided by STEMCELL's Contract Assay Services department, allow researchers to make cell banks through standardized procedures and then receive detailed assessments of their cell quality. Hence, during the forecast period, the studied segment is expected to witness significant growth as studies related to the research of stem cell treatment rise, and with that, programs and funding towards the establishment of stem cell banks also witness an increase.

US Stem Cell Manufacturing Market is poised to grow at a sustainable CAGR for the next forecast year.

Stem Cell Manufacturing Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Stem Cell Manufacturing Market size was valued at USD 12.58 Billion in 2022 and is poised to grow from USD 13.76 Billion in 2023 to USD 28.23 Billion by 2031, at a CAGR of 9.4% during the forecast period (2024-2031).

The highly competitive global stem cell manufacturing industry includes many companies that compete for market share and a competitive advantage. This market comprises research institutes, biotechnology companies, and international pharmaceutical firms. To strengthen their capability to manufacture stem cells and increase their products, these companies are constantly conducting research and development. The leading companies in the industry are working on innovative manufacturing technologies, improving cell culture techniques, and making stem cell production reproducible and scalable. It is believed that these efforts will be able to capitalize on market opportunities and meet the demand for cell-based therapies. 'Thermo Fisher Scientific, Inc. ', 'Merck KGaA ', 'Lonza Group Ltd. ', 'Danaher Corporation ', 'Sartorius AG ', 'Becton, Dickinson and Company ', 'Eppendorf SE ', 'Corning Incorporated ', 'Bio-Rad Laboratories, Inc. ', 'Takara Bio Inc. ', 'Fujifilm Holdings Corporation ', 'Getinge AB ', 'Terumo Corporation ', 'Bio-Techne Corporation ', 'Himedia Laboratories Pvt. Ltd. ', 'Stemcell Technologies, Inc. ', 'Miltenyi Biotec GmbH ', 'Promocell ', 'Anterogen Co. Ltd. ', 'Cellgenix GmbH ', 'Pluristem Therapeutics Inc. ', 'Daiichi Sankyo ', 'Organogenesis Holdings Inc. ', 'Vericel Corp. ', 'American Cryostem Corp.'

The rising interest in regenerative medicine significantly drives demand for stem cell production. New technologies and methods allow the possible applications of stem cells to increase, for instance, from generating bespoke treatments to managing chronic diseases. This advances the demand for stem cell goods and services in both clinical and research settings and further promotes more funding for the research and development of stem cells.

Combining Cutting-Edge Technologies: One of the key stem cell manufacturing trends includes combination of advanced technologies. With 3D bioprinting and CRISPR gene editing on the rise as the most recent technological advances, this field is moving in strides. Thus, more streamlined and accurate manufacturing of stem cells along with more significant research are to be conducted within this domain, leading to much more productive therapy and subsequent interest and funding.

As per the stem cell manufacturing market forecast, North America dominated the industry. Among such drivers of growth are the intensive stem cell research, significant public-private funding and grant for the clinical evaluation of stem cells for various purposes, a robust research infrastructure, and growing public appreciation of the therapeutic potential of stem cells. For instance, in April 2022, the Stem Cell Network (SCN) of Canada revealed IGNITE 2022-2025, which is the three-year strategic plan funded by the Government of Canada under its commitment from Budget 2021 for USD 45 million. Training, knowledge mobilization, and research can be announced to be the three main pillars of IGNITE 2022-2025. As SCN is set out to put scientists and the knowledge that emanates from Canada at the helm of world regenerative medicine (RM), each is very core to it.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Stem Cell Manufacturing Market Insights

Stem Cell Manufacturing Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Stem Cell Manufacturing Market?

Who are the key vendors in the Stem Cell Manufacturing Market?

What is the key driver of Stem Cell Manufacturing Market?

What is the key market trend for Stem Cell Manufacturing Market?

Which region accounted for the largest share in Stem Cell Manufacturing Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300